Intellia Therapeutics, Inc. (NTLA)
8.99
-0.07
(-0.77%)
USD |
NASDAQ |
Dec 31, 16:00
9.02
+0.03
(+0.33%)
After-Hours: 20:00
Intellia Therapeutics Free Cash Flow: -412.63M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| ANI Pharmaceuticals, Inc. | 136.04M |
| Regeneron Pharmaceuticals, Inc. | 3.881B |
| Beam Therapeutics, Inc. | -352.36M |
| Vertex Pharmaceuticals, Inc. | 3.337B |
| Pacific Biosciences of California, Inc. | -131.26M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -76.90M |
| Cash from Investing (Quarterly) | -0.741M |
| Cash from Financing (Quarterly) | 114.86M |
| Free Cash Flow Per Share (Quarterly) | -0.6982 |
| Free Cash Flow to Equity (Quarterly) | -72.30M |
| Free Cash Flow to Firm (Quarterly) | -76.93M |
| Free Cash Flow Yield | -43.79% |